OUR PORTFOLIO

By being vertically integrated and owning all steps of the pharmaceutical development and production process, Accord can bring high quality medicines to patients faster, more economically and with greater efficiency than our rivals.

Accord has one of the most dynamic product pipelines in the pharmaceutical industry. Already we boast a portfolio of over 130 molecules across multiple therapeutic classes. We are committed to build up this number to compete with the largest product ranges in the sector. To date, we have gained nearly 7,000 marketing authorizations across the European Economic Area.

Accord has a particular focus on encouraging the safe use of our products, both for patients and medical professionals

PRODUCT SAFETY MEASURES

Our entire range of product packaging has been designed to minimise the incidence of errors in dispensing, preparing and administering of our medicines.

Accord's portfolio comprises a multitude of different pharmaceutical forms, including; tablets (standard, film-coated, effervescent, sustained release, cytotoxic and immunosuppressant), capsules, cytotoxic injectables (powders and solution vials), non-cytotoxic (ampoules) and controlled drugs.

With oncology products, we undertake a Preventative and Protective approach to occupational exposure. All cytotoxic containing products undergo a rigorous cleaning protocol to minimise possible external residue before being wrapped in our PharmaShield ® technology.

 
 

Cardiovascular

 

Amlodipine
Losartan Potassium and HTCZ
Pravastatin Na

Anti-Diabetes and Endocrine

 

Finasteride
Glimepiride
Metformin HCl
Pioglitazone

Musculo-Skeletal

 

Alendronate Na

Critical Care

 

Cisatracurium Besylate

Central Nervous System

 

Escitalopram
Midazolam
Naltrexone
Risperidone
Ropinirole

 

Dermatology

 

Vitamin A and D Ointment

Supplements

 

Calcium
Calcium and Vitamin D

Gastro-Intestinal Tract

 

Omeprazole

 

Oncology

 

Azacitidine
Anastrozole
Busulfan Maleate
Bortezomib
Bicalutamide
Cabazitaxel
Carboplatin
Capecitabine
Cisplatin
Doxorubicin
Docetaxel
Epirubicin
Finasteride

Filgrastim
Gemcitabine
Ibandronic Acid
Imatinib
Irinotecan
Letrozole
Ondansetron
Oxaliplatin
Paclitaxel
Pemetrexed
Temozolomide
Vincristine